The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

被引:61
作者
Mooradian, AD
Haas, MJ
Wong, NCW
机构
[1] St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63104 USA
[2] Univ Calgary, Dept Med & Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.1210/er.2005-0013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the fractional clearance rate, as well as the rate of apo A-I gene expression. Because medical nutrition therapy constitutes the cornerstone of management of dyslipidemias, it is essential to understand the mechanisms underlying the changes in HDL level in response to alterations in dietary intake. In this review, we will discuss the effect of select nutrients on serum HDLc and apo A-I levels. Specifically, we will review the literature on the effect of carbohydrates, fatty acids, and ketones, as well as some of the nutrient-related metabolites, such as glucosamine and the prostanoids, on apo A-I gene expression. Because there are multiple mechanisms involved in the regulation of serum HDLc levels, changes in gene transcription do not necessarily correlate with clinical observations on serum levels of HDLc.
引用
收藏
页码:2 / 16
页数:15
相关论文
共 136 条
  • [71] Apolipoprotein A(1) expression in young and aged rats is modulated by dietary carbohydrates
    Mooradian, AD
    Wong, NCN
    Shah, GN
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (10): : 1132 - 1136
  • [72] EFFECTS OF INSULIN AND GLUCOSE ON CULTURED RAT HEPATOCYTE GENE-EXPRESSION
    MOORADIAN, AD
    MARIASH, CN
    [J]. DIABETES, 1987, 36 (08) : 938 - 943
  • [73] Cardiovascular disease in type 2 diabetes mellitus - Current management guidelines
    Mooradian, AD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (01) : 33 - 40
  • [74] Apolipoprotein A-I expression in rats is not altered by troglitazone
    Mooradian, AD
    Haas, MJ
    Chehade, J
    Wong, NCW
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (11) : 1001 - 1005
  • [75] MOORADIAN AD, IN PRESS METABOLISM
  • [76] Mooradian Arshag D, 2002, Treat Endocrinol, V1, P13, DOI 10.2165/00024677-200201010-00002
  • [77] Effects of glucose and insulin on rat apolipoprotein A-I gene expression
    Murao, K
    Wada, Y
    Nakamura, T
    Taylor, AH
    Mooradian, AD
    Wong, NCW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) : 18959 - 18965
  • [78] VITAMIN-A REGULATES THE EXPRESSION OF APOLIPOPROTEIN AL AND CIII GENES IN THE RAT
    NAGASAKI, A
    KIKUCHI, T
    KURATA, K
    MASUSHIGE, S
    HASEGAWA, T
    KATO, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (03) : 1510 - 1517
  • [79] Nicolosi RJ, 1998, J LIPID RES, V39, P1972
  • [80] Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner:: the Framingham Study
    Ordovas, JM
    Corella, D
    Cupples, LA
    Demissie, S
    Kelleher, A
    Coltell, O
    Wilson, PWF
    Schaefer, EJ
    Tucker, K
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (01) : 38 - 46